The two companies have entered into a definitive agreement for Genmab to acquire ProfoundBio in an all-cash transaction.
Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing.
Genmab will acquire ProfoundBio for USD 1.8 billion in cash, payable at closing.
“The propo